# Role of Ivermectin and Colchicine in Treatment of COVID-19: Randomized Controlled Clinical Trial

> **NCT05930002** · NA · COMPLETED · sponsor: **Ain Shams University** · enrollment: 120 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Ivermectin Tablets
- **DRUG:** Colchicine 0.5 MG
- **DRUG:** Standared managment

## Key facts

- **NCT ID:** NCT05930002
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-21
- **Primary completion:** 2022-09-09
- **Final completion:** 2022-12-28
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2023-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05930002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05930002, "Role of Ivermectin and Colchicine in Treatment of COVID-19: Randomized Controlled Clinical Trial". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05930002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*